BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer
Shi, Ruoshi, Filho, Sebastiao N. Martins, Li, Ming, Fares, Aline, Weiss, Jessica, Pham, Nhu-An, Ludkovski, Olga, Raghavan, Vibha, Li, Quan, Ravi, Deepti, Cabanero, Michael, Moghal, Nadeem, Leighl, NatJournal:
Lung Cancer
DOI:
10.1016/j.lungcan.2020.05.018
Date:
May, 2020
File:
PDF, 2.12 MB
2020